Oramed Pharmaceuticals Inc. (OTC BB: ORMP)

Oramed Pharmaceuticals Inc. (OTC BB: ORMP), a commercial drug development company, is applying proprietary expertise in integrative pharmacology to potentially discover new uses for drug candidates. Currently, the company is committing their efforts to developing certain compounds for new uses. Compounds in Ore’s development pipeline include: romazarit (for metabolic disorders), tiapamil (for treatment of diseases of the central nervous system), and GL1001 (for inflammatory bowel disease). For further information, visit the Company’s web site at www.oramed.com.